Bay Street News, December 4th, 2018

Phase 2 cancer study will evaluate T cell-activating immunotherapy MEDI0457 with MedImmune’s durvalumab targeting several HPV-related cancers PLYMOUTH MEETING, Pa., Dec. […]

FSR Clinical Studies Network to assist with clinical site initiation to expedite patient enrollment SAN DIEGO, Dec. 04, 2018 (GLOBE […]

Acquisition aligns with Nasdaq’s strategy to expand technology and analytics offering NEW YORK and TORONTO, Dec. 04, 2018 (GLOBE NEWSWIRE) […]

Recognition Based on User Feedback and Ratings REDWOOD CITY, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) — Talend (NASDAQ: TLND), a […]

Poster highlights enrichment strategies for clinical trials in ALS NEW YORK, Dec. 04, 2018 (GLOBE NEWSWIRE) — BrainStorm Cell Therapeutics […]

AIB customers first in Ireland to benefit from easier, faster and more secure banking through Nuance’s fraud-preventing biometrics authentication technology […]

Appointment Adds Significant Scientific Breadth to Board SAN FRANCISCO, Dec. 04, 2018 (GLOBE NEWSWIRE) — UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], […]

IRVINE, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) — Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical […]

SANTA FE, N.M., Dec. 04, 2018 (GLOBE NEWSWIRE) — Sigma Labs, Inc. (NASDAQ: SGLB) (“Sigma Labs” or the “Company”), a […]

Rigorous audit applied to all MGP facilities ATCHISON, Kan., Dec. 04, 2018 (GLOBE NEWSWIRE) — MGP (Nasdaq: MGPI) production facilities […]